Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Cloud leaders Amazon, Google and Microsoft show the once-booming market is cooling down

    February 5, 2023

    Fears of fire after Grenfell tragedy are 'holding back switch to building with wood'

    February 5, 2023

    BMW in talks with UK government over £75m grant for electric Mini

    February 5, 2023
    Facebook Twitter LinkedIn
    Trending
    • Cloud leaders Amazon, Google and Microsoft show the once-booming market is cooling down
    • Fears of fire after Grenfell tragedy are 'holding back switch to building with wood'
    • BMW in talks with UK government over £75m grant for electric Mini
    • Woman, 74, attacked by dog describes 'screaming' in pain with 'flesh everywhere'
    • 'It's painful': US facing record-breaking wind chill factors so cold they're literally off the charts
    • Arlington Heights-based school district eyes lobbyist as talks of Bears move, tax deals heat up in Springfield
    • Ticker: Gas prices dip around nation as cold weather returns
    • Why a new Alzheimer’s drug is having a slow US debut
    Facebook Twitter LinkedIn
    Business KhabarBusiness Khabar
    • World
    • Auto
    • Business
      • Industries
      • Opinion
    • Market
    • Money
      • Finance
      • Insurance
      • Investment
      • Schemes
    • Sports
    • Other
      • Stories
      • Career
      • Entrepreneurship
      • Property
    • Web Stories
    Business KhabarBusiness Khabar
    Home » Coronavirus: Pfizer and BioNtech seek vaccine approval for children, to be monitored for two years
    News

    Coronavirus: Pfizer and BioNtech seek vaccine approval for children, to be monitored for two years

    ShehnazBy ShehnazApril 30, 2021Updated:June 4, 2022No Comments
    Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
    Coronavirus: Pfizer and BioNtech seek vaccine approval for children, to be monitored for two years
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Pfizer and BioNotech previously requested that their emergency use license be extended to 12–15-year-olds with the US Food and Drug Administration (USFDA) as well.

    Symbolic picture

    Pfizer BioNTech Seeks Vaccine Approval For Children in Europe: A vaccination campaign is going on worldwide to beat the Coronavirus. In countries which have given vaccine to their maximum population, the situation is under control. Meanwhile, Pfizer and BioNtech have sought approval for the Pfizer BioNTech Vaccine for Children. Pfizer and BioNotech have requested EU drug regulators to approve the companies’ corona virus vaccine for children between the ages of 12 and 15 years.

    This step may provide access to the vaccine to young and low-risk populations in Europe. The two companies said in a statement on Friday that their application to the European Medicines Agency was based on an advanced study conducted on more than 2,000 teenagers. In which the vaccine was found to be safe and effective. Children will be monitored for long-term protection for another two years.

    EME gave approval

    Pfizer and BioNotech had previously requested that their emergency use license be extended to 12–15-year-olds with the US Food and Drug Administration as well. The COVID-19 vaccine, created by Pfizer and BioNotech, was the first vaccine approved by the EMA last December (Pfizer BioNTech Vaccine Approval), when it was introduced to people 16 years and older and the 27-country European Union. Was licensed in According to media reports, Pfizer and BioNotech’s COVID-19 vaccine is quite effective.

    Single dose of vaccine is also beneficial

    Researchers in the UK and the US had found out the efficacy of a dose of Pfizer and BioNtech’s Vaccine and AstraZeneca’s Vaccine (Pfizer BioNTech Vaccine Effectiveness). In which it was found that the rate of infection is lower in people taking the vaccine as compared to those who do not take the vaccine. According to Lancet, the risk of infection decreases by 58 percent after 12 to 20 days of taking single dose of Pfizer and Bioentech vaccine, 69 percent after 21 to 44 days and 45 to 59 days. After that the risk is reduced by 72 per cent.

    Also read- The oldest ‘water’ ever found on Earth, is 160 million years old, know why it increased the chances of life on Mars now?

    Also read- Xi Jinping sent message to PM Modi, said- China is ready to help in the fight with COVID

    .

    corona vaccine Coronavirus Pfizer BioNTech Vaccine Side Effects pfizer-biontech vaccine Vaccination in Europe vaccine for children Vaccine for Coronavirus World News in Hindi
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Shehnaz
    • Website
    • Twitter
    • LinkedIn

    Shehnaz is a Corporate Communications Expert by profession and writer by Passion. She has experience of many years in the same. Her educational background in Mass communication has given her a broad base from which to approach many topics. She enjoys writing about Public relations, Corporate communications, travel, entrepreneurship, insurance, and finance among others.

    Related Posts

    Ticker: Gas prices dip around nation as cold weather returns

    February 5, 2023

    Why a new Alzheimer’s drug is having a slow US debut

    February 5, 2023

    Man arrested in Dallas Zoo monkey theft

    February 4, 2023
    Top Post

    Home Showcase: North End condo is roomy and cool

    February 4, 2023

    Ticker: ISO says power will stay on; Treasury makes more electric SUVs eligible for tax credits

    February 4, 2023

    Jury: Musk didn’t defraud investors with 2018 Tesla tweets

    February 4, 2023

    A surprising burst of US hiring in January: 517,000 jobs

    February 4, 2023
    Don't Miss
    Sports

    5 fixes for the 2023 Patriots: No. 4 — Add a starting cornerback with or without Jonathan Jones

    By Bhagyashree SoniJanuary 19, 2023

    The Patriots have gone backwards. After making the postseason in 2021, the Pats completed a…

    Business

    Explosion at luxurious Havana lodge kills 22, injures dozens

    By Business KhabarMay 7, 2022

    By ANDREA RODRÍGUEZ HAVANA (AP) — A robust explosion apparently brought on by a pure…

    Business

    How new-age manufacturers are harnessing the true energy of influencer advertising and marketing

    By Business KhabarMay 22, 2022

    By Deepti Karthik How typically have we bought a shampoo as a result of our…

    Sports

    Yankees blanked by Red Sox, drop series

    By Bhagyashree SoniAugust 15, 2022

    BOSTON — At least it’s over. The Yankees ended a disastrous nine-game, 11-day street journey…

    About Us
    About Us

    Business Khabar: Read latest business news, auto news, technology news, personal finance, industries news, investment & insurance news, startups & success stories.

    We're accepting new partnerships right now.

    Email Us: [email protected]

    Facebook Twitter LinkedIn
    In Case You Missed

    Used car prices drop, but buyers still facing sky high interest rates and tight inventory

    February 4, 2023

    Wall Street rally hits wall of hot jobs, cold earnings data

    February 4, 2023

    Home Showcase: North End condo is roomy and cool

    February 4, 2023
    Last Minute Read

    Super-tight policy is still struggling to control inflation

    February 3, 2023

    Rallying markets suffer from a doveish illusion

    February 2, 2023

    Rake in the Cash with These Credit Card Sign Up Bonuses

    February 2, 2023
    Facebook Twitter LinkedIn
    • About us
    • Contact
    • Contribute for us
    • Privacy Policy
    • Disclaimer
    © 2023 Business Khabar. Designed by ThemeSphere.

    Type above and press Enter to search. Press Esc to cancel.